ClinicalTrials.Veeva

Menu

Heterotopic Ossification in Abdominal Incision and Pancreatic Cancer

N

Nanjing Medical University

Status

Not yet enrolling

Conditions

Cancer of Pancreas
Ossification, Heterotopic

Treatments

Diagnostic Test: Bone alkaline phosphatase
Radiation: Abdominal CT scan

Study type

Observational

Funder types

Other

Identifiers

NCT04049461
NMU-JSPH-PC-Ossification

Details and patient eligibility

About

To investigate whether pancreatic cancer is the cause of heterotopic ossification of abdominal incision.

Full description

Heterotopic ossification of abdominal incision (HOAI) has long been regarded as a rare complication after general surgery. However,according to our retrospective analysis. HOAI was more frequently observed in the malignancy group (33/121 cases, 27.3%) than in the non- malignancy group. Because of the many biases in the retrospective analysis, the result was not widely shared.

The purpose of this prospective study is to confirm that pancreatic cancer is the cause of heterotopic ossification of abdominal incisions. According to postoperative pathology, the patients were divided into two groups: pancreatic cancer group and benign diseases group.The researchers will observe whether patients develop heterotopic ossification of the abdominal incision one year after surgery to conclude.

Enrollment

105 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Obtain informed consent from the patients.
  • The patient's abdominal incision was double-closed with continuous suture of linea alba and fascia with absorbable suture, and skin was sutured with skin staples.

Exclusion criteria

  • Refusing to join the study
  • Previous history of malignant tumor
  • Previous history of midabdominal incision
  • Abnormal calcium and phosphorus metabolism
  • Distant metastasis
  • Palliative operation
  • performing neoadjuvant chemotherapy

Trial design

105 participants in 2 patient groups

PDAC Group
Description:
Radical operations were performed through central abdominal incisions. The postoperative pathology was pancreatic ductal adenocarcinoma.
Treatment:
Diagnostic Test: Bone alkaline phosphatase
Radiation: Abdominal CT scan
Benign Group
Description:
The abdominal midline incision was performed and the postoperative pathology was benign.
Treatment:
Diagnostic Test: Bone alkaline phosphatase
Radiation: Abdominal CT scan

Trial contacts and locations

1

Loading...

Central trial contact

Jishu Wei, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems